{"altmetric_id":2824592,"counts":{"readers":{"mendeley":10,"citeulike":0,"connotea":0},"total":{"posts_count":3},"twitter":{"unique_users_count":1,"unique_users":["clinthe"],"posts_count":3}},"selected_quotes":["How do pharmacokinetic #bridging #studies support the development of novel delivery devices for #biologics? #medcomms","How do #Pharmacokinetics bridging studies support the development of novel delivery devices for #biologics? #medcomms","Pharmacokinetic Bridging Approach for Developing Biologics-Delivery Devices: A Case Study W... #medcomms #pubplan"],"citation":{"abstract":"This Phase 1 pharmacokinetic (PK) comparability study in healthy subjects was performed to compare the PK properties and tolerability of single-dose golimumab 100 mg delivered subcutaneously by an autoinjector device or by a standard needle and syringe that had been used for the subcutaneous (SC) delivery of golimumab in pivotal Phase 3 studies.","abstract_source":"pubmed","altmetric_jid":"4f6fa4ea3cf058f61000257d","doi":"10.1016\/j.clinthera.2014.09.012","first_seen_on":"2014-10-30T07:33:22+00:00","issns":["0149-2918"],"journal":"Clinical Therapeutics","last_mentioned_on":1424219672,"links":["https:\/\/secure.jbs.elsevierhealth.com\/action\/getSharedSiteSession?rc=8&redirect=http%3A%2F%2Fwww.clinicaltherapeutics.com%2Farticle%2FS0149-2918%252814%252900604-3%2Fabstract%3Frss%3Dyes&code=clithe-site","https:\/\/secure.jbs.elsevierhealth.com\/action\/getSharedSiteSession?rc=8&redirect=http%3A%2F%2Fwww.clinicaltherapeutics.com%2Farticle%2FS0149-2918%252814%252900604-3%2Fabstract&code=clithe-site"],"pdf_url":"http:\/\/www.clinicaltherapeutics.com\/article\/S0149291814006043\/pdf","pmid":"25438720","publisher":"Elsevier","publisher_subjects":[{"name":"Pharmacology And Pharmaceutical Sciences","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Pharmacology, Toxicology and Pharmaceutics"],"subjects":["drugtherapy"],"title":"Pharmacokinetic Bridging Approach for Developing Biologics-Delivery Devices: A Case Study With a Golimumab Autoinjector","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/pharmacokinetic-bridging-approach-developing-biologicsdelivery-devices-case-study-golimumab-autoinje"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":4778173,"mean":5.7247390918571,"rank":3385561,"this_scored_higher_than_pct":16,"this_scored_higher_than":777093,"rank_type":"exact","sample_size":4778173,"percentile":16},"similar_age_3m":{"total_number_of_other_articles":132976,"mean":8.8044974318483,"rank":90871,"this_scored_higher_than_pct":19,"this_scored_higher_than":26088,"rank_type":"exact","sample_size":132976,"percentile":19},"this_journal":{"total_number_of_other_articles":1137,"mean":2.3475088028169,"rank":714,"this_scored_higher_than_pct":28,"this_scored_higher_than":326,"rank_type":"exact","sample_size":1137,"percentile":28},"similar_age_this_journal_3m":{"total_number_of_other_articles":8,"mean":2.9654285714286,"rank":6,"this_scored_higher_than_pct":12,"this_scored_higher_than":1,"rank_type":"exact","sample_size":8,"percentile":12}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Researcher":3,"Student  > Doctoral Student":1,"Student  > Ph. D. Student":3,"Student  > Master":1,"Student  > Bachelor":1,"Student  > Postgraduate":1},"by_discipline":{"Medicine and Dentistry":4,"Agricultural and Biological Sciences":3,"Biochemistry, Genetics and Molecular Biology":1,"Pharmacology, Toxicology and Pharmaceutical Science":2}}},"geo":{"twitter":{"US":1},"mendeley":{"BE":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/clinthe\/status\/541738065048653825","license":"datasift","citation_ids":[2824592],"posted_on":"2014-12-07T23:36:34+00:00","author":{"name":"clinicaltherapeutics","url":"http:\/\/www.clinicaltherapeutics.com\/home","image":"https:\/\/pbs.twimg.com\/profile_images\/901963433616306176\/3626f_ib_normal.jpg","description":"Elsevier peer-reviewed rapid dissemination of reliable and evolving evidence derived from clinical pharmacology and other therapeutic approaches.","id_on_source":"clinthe","tweeter_id":"372351408","geo":{"lt":39.76,"ln":-98.5,"country":"US"},"followers":1068},"tweet_id":"541738065048653825"},{"url":"https:\/\/twitter.com\/clinthe\/status\/527272628315107328","license":"datasift","citation_ids":[2824592],"posted_on":"2014-10-29T01:36:05+00:00","author":{"name":"clinicaltherapeutics","url":"http:\/\/www.clinicaltherapeutics.com\/home","image":"https:\/\/pbs.twimg.com\/profile_images\/901963433616306176\/3626f_ib_normal.jpg","description":"Elsevier peer-reviewed rapid dissemination of reliable and evolving evidence derived from clinical pharmacology and other therapeutic approaches.","id_on_source":"clinthe","tweeter_id":"372351408","geo":{"lt":39.76,"ln":-98.5,"country":"US"},"followers":1068},"tweet_id":"527272628315107328"},{"url":"https:\/\/twitter.com\/clinthe\/status\/567844577731813376","license":"datasift","citation_ids":[2824592],"posted_on":"2015-02-18T00:34:32+00:00","author":{"name":"clinicaltherapeutics","url":"http:\/\/www.clinicaltherapeutics.com\/home","image":"https:\/\/pbs.twimg.com\/profile_images\/901963433616306176\/3626f_ib_normal.jpg","description":"Elsevier peer-reviewed rapid dissemination of reliable and evolving evidence derived from clinical pharmacology and other therapeutic approaches.","id_on_source":"clinthe","tweeter_id":"372351408","geo":{"lt":39.76,"ln":-98.5,"country":"US"},"followers":1068},"tweet_id":"567844577731813376"}]}}